David Joseph Topper - 10 Apr 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Chief Financial Officer
Signature
/s/ Masaru Matsuda, Attorney-on-Fact for David Topper
Issuer symbol
ARQT
Transactions as of
10 Apr 2024
Net transactions value
$0
Form type
4
Filing time
11 Apr 2024, 20:32:50 UTC
Previous filing
23 Nov 2022
Next filing
25 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Award $0 +110,000 $0.000000 110,000 10 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (right to buy) Award $0 +310,000 $0.000000 310,000 10 Apr 2024 Common Stock 310,000 $12.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of April 10, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
F2 The option will vest and become exercisable as to 25% of the shares on the first annual anniversary of the grant date of April 10, 2024, and the remaining options will vest at 2.0833%, on each monthly anniversary thereafter, subject to the Reporting Person's continued service through the applicable vesting date.